Stay updated on Risankizumab in Psoriatic Arthritis Clinical Trial
Sign up to get notified when there's something new on the Risankizumab in Psoriatic Arthritis Clinical Trial page.

Latest updates to the Risankizumab in Psoriatic Arthritis Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe study record status changed from Active, not recruiting to Completed, indicating that participant enrollment has ended. This update also notes a new last update date (2026-07-20) and a revision bump to v3.6.4.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check33 days agoChange DetectedRevision: v3.6.3 is now displayed, replacing Revision: v3.6.2. This appears to be a versioning/template update rather than a change to page content or user-facing information.SummaryDifference0.0%

- Check40 days agoChange DetectedThe page revision identifier has been updated from v3.6.0 to v3.6.2, signaling a newer version of the page's metadata. This change reflects a behind-the-scenes update and does not modify the main content visible to users.SummaryDifference0.0%

- Check54 days agoChange DetectedNew reader guidance sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention label formatting changed from 'Intervention / Treatment' to 'Intervention/Treatment'. A recruitment-status note ('No longer looking for participants') was added and the page revision indicator updated to 'Revision: v3.6.0'.SummaryDifference0.2%

- Check61 days agoChange DetectedA new revision label with v3.5.5 has been added to the page, signaling an updated document version without changing the substantive content.SummaryDifference0.0%

- Check76 days agoChange DetectedThe Related Info section, the AbbVie sponsor block, and the Helpful Links Provided by footer were removed. This reduces sponsor attribution and auxiliary links from the page while preserving the main study details.SummaryDifference0.1%

Stay in the know with updates to Risankizumab in Psoriatic Arthritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab in Psoriatic Arthritis Clinical Trial page.